Interpace Biosciences, Inc. (IDXG) stock
IDXGOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$5.00−0.15 (-2.91%)
Close on Oct 19, 2026Market cap $138.57MP/E 5.6Yield –
Interpace Biosciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Interpace Biosciences's price to sales ratio was 3.8× on Oct 19, 2026, against 0.1× a year earlier. Over the last 2 years it ranged from 0.1× to 5.8×, with a median of 0.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 3.8× | +3.7 |
| 2025 | Dec 31, 2025 | 0.1× | −0.1 |
| 2024 | Dec 31, 2024 | 0.3× | – |
See a number that looks wrong?